Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytek Biosciences (CTKB) Exchange Rate Effect (2020 - 2025)

Historic Exchange Rate Effect for Cytek Biosciences (CTKB) over the last 6 years, with Q3 2025 value amounting to $846000.0.

  • Cytek Biosciences' Exchange Rate Effect rose 18971.37% to $846000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $215000.0, marking a year-over-year decrease of 9018.71%. This contributed to the annual value of $4.5 million for FY2024, which is 41363.32% up from last year.
  • As of Q3 2025, Cytek Biosciences' Exchange Rate Effect stood at $846000.0, which was up 18971.37% from -$921000.0 recorded in Q2 2025.
  • In the past 5 years, Cytek Biosciences' Exchange Rate Effect registered a high of $2.3 million during Q2 2024, and its lowest value of -$1.4 million during Q2 2022.
  • Over the past 5 years, Cytek Biosciences' median Exchange Rate Effect value was -$6000.0 (recorded in 2021), while the average stood at $31368.4.
  • Data for Cytek Biosciences' Exchange Rate Effect shows a peak YoY increase of 223333.33% (in 2022) and a maximum YoY decrease of 103400.0% (in 2022) over the last 5 years.
  • Over the past 5 years, Cytek Biosciences' Exchange Rate Effect (Quarter) stood at $678000.0 in 2021, then tumbled by 247.79% to -$1.0 million in 2022, then rose by 17.86% to -$823000.0 in 2023, then surged by 284.45% to $1.5 million in 2024, then crashed by 44.27% to $846000.0 in 2025.
  • Its last three reported values are $846000.0 in Q3 2025, -$921000.0 for Q2 2025, and -$1.2 million during Q1 2025.